Gufic Biosciences (NSE:GUFICBIO) COGS-to-Revenue : 0.47 (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences COGS-to-Revenue?

Gufic Biosciences's Cost of Goods Sold for the three months ended in Sep. 2024 was ₹961 Mil. Its Revenue for the three months ended in Sep. 2024 was ₹2,042 Mil.

Gufic Biosciences's COGS to Revenue for the three months ended in Sep. 2024 was 0.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Gufic Biosciences's Gross Margin % for the three months ended in Sep. 2024 was 52.92%.

Gufic Biosciences COGS-to-Revenue Historical Data

The historical data trend for Gufic Biosciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences COGS-to-Revenue Chart

Gufic Biosciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.52

0.59

0.50

0.52

Gufic Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															0.51	0.47	0.62	0.47	0.47

Gufic Biosciences COGS-to-Revenue Calculation

Gufic Biosciences's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3992.924	/	7696.562
	=	0.52

Gufic Biosciences's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	961.29	/	2041.799
	=	0.47

Gufic Biosciences (NSE:GUFICBIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Gufic Biosciences's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	961.29 / 2041.799
	=	52.92 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Gufic Biosciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gufic Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

509079:India

Address

SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057

Website

https://www.gufic.com

Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines